[1] |
世界卫生组织.病毒性肝炎感染的预防与控制:全球行动框架[EB/OL].Http://www.who.int/topics/hepatitis/zh/健康主题/肝炎.
|
[2] |
世界卫生组织.乙型肝炎[EB/OL].Http://www.who.int/topics/hepatitis/zh/媒体中心/实况报道,第204号.
|
[3] |
世界卫生组织.乙型肝炎免疫接种纳入儿童常规免疫服务[EB/OL].Http://www.who.int/publications/list/who_vb_01_31/zh/.
|
[4] |
Zanetti AR,Van Damme P,Shouval D.The global impact of vaccination against hepatitis B:a historical overview[J].Vaccine,2008,26(49):6266-73.
|
[5] |
Shrestha P,Bhandari D,Sharma D,et al.A study of viral hepatitis during pregnancy in Nepal Medical College Teaching Hospital[J].Nepal Med Coll J,2009,11(3):192-194.
|
[6] |
El-Magrahe H,Furarah AR,El-Figih K,et al.Maternal and neonatal seroprevalence of hepatitis B surface antigen(HBsAg)in Tripoli,Libya[J].J Infect Dev Ctries,2010,4(3):168-170.
|
[7] |
Zhang S,Li RT,Wang Y,et al.Seroprevalence of hepatitis B surface antigen among pregnant women in Jiangsu,China,17 years after introduction of hepatitis B vaccine[J].Int J Gynaecol Obstet,2010,109(3):194-197.
|
[8] |
Yuen MF,Lee CK,Wong DK,et al.Prevalence of occult hepatitis B infection in a highly endemic area for chronic hepatitis B:a study of a large blood donor population[J].Gut,2010,59(10):1389-1393.
|
[9] |
Acar A,Kemahli S,Altunay H,et al.HBV,HCV and HIV seroprevalence among blood donors in Istanbul,Turkey:how effective are the changes in the national blood transfusion policies?[J].Braz J Infect Dis,2010,14(1):41-46.
|
[10] |
WHO.Blood transfusion safety[EB/OL].Http://www.who.int/bloodsafety/en/Blood-Transfusion-Safety/.
|
[11] |
Tiwari BR,Ghimire P,Kandel SR,et al.Seroprevalence of HBV and HCV in blood donors:a study from regional blood transfusion services of Nepal[J].Asian J Transfus Sci,2010,4(2):91-93.
|
[12] |
McClune AC,Tong MJ.Chronic hepatitis B and hepatocellular carcinoma[J].Clin Liver Dis,2010,14(3):461-476.
|
[13] |
Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma.Prevention of hepatocellular carcinoma in the Asia-Pacific region:consensus statements[J].J Gastroenterol Hepatol,2010,25(4):657-663.
|
[14] |
Elisabetta F,Barbara B,Maria GM,et al.Hepatitis B:epidemiology and prevention in developing countries[J].World J Hepatol,2012,4(3):74-80.
|
[15] |
陈华,张菊英,何芳,等.绵阳市1-15岁儿童乙肝疫苗免疫效果调查[J].中国公共卫生,2014,30(7):884-886.
|
[16] |
Chen DS.Toward elimination and eradication of hepatitis B[J].J Gastroenterol Hepatol,2010,25(1):19-25.
|
[17] |
世界卫生组织.中国乙肝疫苗接种常见问题[EB/OL].Http://www.wpro.who.int/china/mediacentre/releases/2014/20140818/zh/.
|
[18] |
世界卫生组织.及时接种乙肝疫苗出生剂次是获得终生保护的关键[EB/OL].Http://www.wpro.who.int/china/mediacentre/releases/2014/20140424/zh/.
|
[19] |
Monica CR.Hepatitis B prevention and control:lessons from the East and the West[J].World J Hepatol,2011,3(2):31-37.
|
[20] |
王平贵,高丽,安婧袁,等.甘肃省新生儿乙肝疫苗首针及时接种率试点项目评价[J].中国公共卫生,2013,29(8):1199-1202.
|
[21] |
刘彩.农村儿童乙肝疫苗首针及时接种现状及影响因素[J].中国公共卫生,2014,30(12):1496-1499.
|